BOD Science (BOD) Short Interest
BOD Science (ASX:BOD) had 0.00% of shares reported as short positions as of 23 Oct 2023, representing 1,681 shares. BOD Science operates in the Consumer Discretionary Distribution & Retail industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
BOD Science
Bod Science Limited (ASX:BOD) is a global life science healthcare company specializing in cannabis-centric products and solutions. The company is dedicated to innovating and transforming lives by delivering premium, proven, and trusted cannabinoid-based medications. It actively engages in clinical research, such as the CAN-REST study for insomnia, and provides comprehensive resources for accessing medicinal cannabis and informing both consumers and medical professionals.
Short position
BOD Science (ASX:BOD) has 0.00% of its shares on issue reported as short positions as of 23 Oct 2023, or about 1,681 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. BOD is classified in the Consumer Discretionary Distribution & Retail industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4BOD intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of BOD SCIENCE LIMITED
Latest BOD news
All newsAbout
More Consumer Discretionary Distribution & Retail Stocks
Other shorted stocks in this sector
Be the first to discuss BOD
Start a research thread or post the first pulse update